10001 related articles for article (PubMed ID: 12187481)
1. p53 Immunoreactivity, Ki-67 expression, and microcirculation patterns in melanoma of the iris, ciliary body, and choroid.
Chowers I; Folberg R; Livni N; Pe'er J
Curr Eye Res; 2002 Feb; 24(2):105-8. PubMed ID: 12187481
[TBL] [Abstract][Full Text] [Related]
2. Comparison of microcirculation patterns and MIB-1 immunoreactivity in iris and posterior uveal melanoma.
Chowers I; Folberg R; Livni N; Pe'er J
Ophthalmology; 2001 Feb; 108(2):367-71. PubMed ID: 11158814
[TBL] [Abstract][Full Text] [Related]
3. p53 expression in uveal malignant melanomas.
Jay V; Yi Q; Hunter WS; Zielenska M
Pathology; 1996 Nov; 28(4):306-8. PubMed ID: 9007946
[TBL] [Abstract][Full Text] [Related]
4. KI-67 immunopositivity in choroidal and ciliary body melanoma with respect to nucleolar diameter and other prognostic factors.
Al-Jamal RT; Kivelä T
Curr Eye Res; 2006 Jan; 31(1):57-67. PubMed ID: 16421020
[TBL] [Abstract][Full Text] [Related]
5. Expression of vascular endothelial growth factor a, matrix metalloproteinase 9 and extravascular matrix patterns in iris and ciliary body melanomas.
Sahin A; Kiratli H; Tezel GG; Soylemezoglu F; Bilgic S
Ophthalmic Res; 2007; 39(1):40-4. PubMed ID: 17164576
[TBL] [Abstract][Full Text] [Related]
6. Microcirculation patterns other than loops and networks in choroidal and ciliary body melanomas.
Folberg R; Chen X; Boldt HC; Pe'er J; Brown CK; Woolson RF; Maniotis AJ
Ophthalmology; 2001 May; 108(5):996-1001. PubMed ID: 11320035
[TBL] [Abstract][Full Text] [Related]
7. Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth.
Boyd SR; Tan DS; de Souza L; Neale MH; Myatt NE; Alexander RA; Robb M; Hungerford JL; Cree IA
Br J Ophthalmol; 2002 Apr; 86(4):440-7. PubMed ID: 11914215
[TBL] [Abstract][Full Text] [Related]
8. The correlation among different immunostaining evaluation methods for the assessment of proliferative activity in uveal melanoma.
Chowers I; Amer R; Pe'er J
Curr Eye Res; 2002 Dec; 25(6):369-72. PubMed ID: 12789544
[TBL] [Abstract][Full Text] [Related]
9. Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study.
Pe'er J; Stefani FH; Seregard S; Kivela T; Lommatzsch P; Prause JU; Sobottka B; Damato B; Chowers I
Br J Ophthalmol; 2001 Oct; 85(10):1208-12. PubMed ID: 11567966
[TBL] [Abstract][Full Text] [Related]
10. Microcirculation architecture of melanocytic nevi and malignant melanomas of the ciliary body and choroid. A comparative histopathologic and ultrastructural study.
Rummelt V; Folberg R; Rummelt C; Gruman LM; Hwang T; Woolson RF; Yi H; Naumann GO
Ophthalmology; 1994 Apr; 101(4):718-27. PubMed ID: 8152768
[TBL] [Abstract][Full Text] [Related]
11. [Expression of bcl-2, Ki-67 and p-53 in uveal melanomas].
Krvavica A; Talan-Hranilović J; Belicza M
Acta Med Croatica; 2008 Jul; 62(3):267-71. PubMed ID: 18843846
[TBL] [Abstract][Full Text] [Related]
12. Relation between the microcirculation architecture and the aggressive behavior of ciliary body melanomas.
Rummelt V; Folberg R; Woolson RF; Hwang T; Pe'er J
Ophthalmology; 1995 May; 102(5):844-51. PubMed ID: 7777286
[TBL] [Abstract][Full Text] [Related]
13. Relative importance of quantifying area and vascular patterns in uveal melanomas.
Mehaffey MG; Folberg R; Meyer M; Bentler SE; Hwang T; Woolson R; Moore KC
Am J Ophthalmol; 1997 Jun; 123(6):798-809. PubMed ID: 9535624
[TBL] [Abstract][Full Text] [Related]
14. Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas.
Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
J Natl Cancer Inst; 1999 Feb; 91(4):359-67. PubMed ID: 10050870
[TBL] [Abstract][Full Text] [Related]
15. Distribution of prognostically important vascular patterns across multiple levels in ciliary body and choroidal melanomas.
Mehaffey MG; Gardner LM; Folberg R
Am J Ophthalmol; 1998 Sep; 126(3):373-8. PubMed ID: 9744370
[TBL] [Abstract][Full Text] [Related]
16. Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma.
Coupland SE; Bechrakis N; Schüler A; Anagnostopoulos I; Hummel M; Bornfeld N; Stein H
Br J Ophthalmol; 1998 Aug; 82(8):961-70. PubMed ID: 9828785
[TBL] [Abstract][Full Text] [Related]
17. Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension?
Heindl LM; Hofmann TN; Adler W; Knorr HL; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2010 Feb; 117(2):334-42. PubMed ID: 19892405
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of PAX8 Immunohistochemistry in Adult Intraocular Tumor Diagnosis.
Mudhar HS; Milman T; Eagle RC; Sanderson T; Pheasey L; Paine S; Salvi S; Rennie IG; Rundle P; Shields CL; Shields JA
Ophthalmology; 2021 May; 128(5):765-778. PubMed ID: 33002562
[TBL] [Abstract][Full Text] [Related]
19. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium?
Ziemssen F; Wegner R; Wegner J; Tatar O; Süsskind D; Gelisken F; Rohrbach M; Bartz-Schmidt KU; Grisanti S
Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1124-31. PubMed ID: 16523306
[TBL] [Abstract][Full Text] [Related]
20. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma.
Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2471-80. PubMed ID: 10509639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
